10,593
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Dapagliflozin for the treatment of type 2 diabetes mellitus – an update

, ORCID Icon &
Pages 2303-2310 | Received 14 Apr 2021, Accepted 06 Jul 2021, Published online: 28 Jul 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.